TLR7 and Bowen disease of the skin: Imiquimod (IMQ), a synthetic toll-like receptor 7 (TLR-7) agonist is an FDA-approved immunotherapy drug which used in actinic keratosis, basal cell carcinoma, and Bowen’s disease treatment [9].